Gleolan

DRUG2 trials

Sponsors

NX Development Corp

Conditions

MeningiomaOvarian Cancer

Phase 3

Gleolan for Visualization of Newly Diagnosed or Recurrent Meningioma

CompletedNCT04305470

NX Development CorpMeningioma

Start: 2020-10-28End: 2022-12-13Updated: 2026-05-18

Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302)

RecruitingNCT05804370

NX Development CorpOvarian Cancer

Start: 2024-05-30End: 2029-05-01Target: 170Updated: 2026-07-14